Prelude Therapeutics (PRLD) Revenue

175 Followers

Statistics Market Cap Revenue

Prelude Therapeutics Revenue

Prelude Therapeutics had a revenue of 5.64M in the quarter ending Dec 31, 2025, with -13.23%. This bring the company's revenue in the last twelve months to 12.14M, Decreased 15.62%. In the fiscal year ending Dec 31, 2025, Prelude Therapeutics had annual revenue of 12.14M with 73.43% growth.

Revenue (ttm)

12.14M

Revenue Growth

250.00%

P/S Ratio

17.90

Revenue/Employee

$92,672

Employees

131

Market Cap

$217.36M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	12.14M	5.14M	+73.43%
Dec 31, 2024	7.00M	―	+∞%
Dec 31, 2023	―	―	―
Dec 31, 2022	―	―	―
Dec 31, 2021	―	―	―
Dec 31, 2020	―	―	―
Dec 31, 2019	―	―	―
Dec 31, 2018	―	―	―